Outpatient endoscopic procedure ‘may be a game changer’ for type 2 diabetes management
A novel endoscopic procedure combined with semaglutide may eliminate the need for insulin while improving glycemic control and metabolic parameters among patients with type 2 diabetes.“Type 2 diabetes is typically treated by a variety of drugs with insulin therapy as the final resort,” Jacques Bergman, MD, PhD, professor of gastrointestinal endoscopy and head of endoscopy…